In recent years, celebrities have turned to Ozempic and similar drugs for weight loss. While the FDA has approved Wegovy and Zepbound for weight management, Ozempic and Mounjaro officially remain medications for type 2 diabetics. According to NPR, shortages due in part to Hollywood’s fondness for the drugs have left many diabetics unable to access the medications they need.
NPR pointed out that the drugmakers themselves have advertised heavily, with some commercials including the number of pounds patients lost even when that particular medication was meant for type 2 diabetics. This, in combination with social media, has also increased demand for using those drugs for weight loss.
